Data layers Raw facts Calculated Model prediction AI interpretation

IPO Timeline Raw facts

Broker Deadline
Morning deadline
HKEX Deadline
Noon deadline
Broker Results (T-2)
Some brokers release in afternoon
Grey Market (T-1)
Afternoon
HKEX Allotment (T-1)
Evening
Registrar Allotment (T-1)
Evening
Listing Day (T)
First day of trading

Company Overview

Stock NameMirxes-B
Stock Code02629
Company Full NameMirxes Holding Company Limited
Industry醫療保健
Principal Activities公司是一家總部位于新加坡的miRNA技術公司,致力于使疾病篩查診斷解決方案在亞洲關鍵市場(包括新加坡及中國)觸手可及。
Listing Date2025-05-23
Listing Rules EraOld Rules
Listing Rules Chapter18A生物科技
Weighted Voting Rights (WVR)No
Registered Address (Mainland China)中國浙江省湖州市安吉縣遞鋪街道半島中路198號2幢1層26號
Business Address (Hong Kong)To be extracted
Place of IncorporationTo be extracted
Listing MethodTo be extracted
Listing BoardMain Board
Websitehttps://mirxes.com/
Share Registrar香港中央證券登記有限公司 (Computershare Hong Kong Investor Services Limited)
Registrar Contact(852)2862 8628
A-Share/US Dual ListingNo

Offering Information

Offering Mechanism 18A生物科技
Offer PriceHK$ 23.30 / shares
Offer Price RangeFinal offer price only, no range
Lot Size100 shares
Entry ThresholdHK$ 2,330
Par ValueTo be extracted
Offer Period2025-05-15 to 2025-05-20
Global Offering Shares46,620,000 shares
HK Public Offer Shares (Initial)To be extracted
Public Offer Lots (Initial)To be extracted
International Placing Shares (Initial)To be extracted
Offer RatioTo be extracted
Total Shares Post-IPOTo be extracted
Greenshoe (Over-allotment Option)No
Stabilizing Manager (Greenshoe)—
Cornerstone Share41.4%
Clawback TiersTo be extracted
Reallocation OptionNo
Total Global Offering SizeHK$ 1,086,246,000

Subscription Tiers

Minimum subscription unit: 1 lot. Subscription amount ≤ HK$5,000,000 is Pool A, > HK$5,000,000 is Pool B.

Pool A
Lots SubscribedShares SubscribedSubscription Amount (HKD)
1 lots 100 HK$ 2,330
2 lots 200 HK$ 4,660
3 lots 300 HK$ 6,990
4 lots 400 HK$ 9,320
5 lots 500 HK$ 11,650
6 lots 600 HK$ 13,980
7 lots 700 HK$ 16,310
8 lots 800 HK$ 18,640
9 lots 900 HK$ 20,970
10 lots 1,000 HK$ 23,300
20 lots 2,000 HK$ 46,600
30 lots 3,000 HK$ 69,900
40 lots 4,000 HK$ 93,200
50 lots 5,000 HK$ 116,500
60 lots 6,000 HK$ 139,800
70 lots 7,000 HK$ 163,100
80 lots 8,000 HK$ 186,400
90 lots 9,000 HK$ 209,700
100 lots 10,000 HK$ 233,000
200 lots 20,000 HK$ 466,000
300 lots 30,000 HK$ 699,000
400 lots 40,000 HK$ 932,000
500 lots 50,000 HK$ 1,165,000
1,000 lots 100,000 HK$ 2,330,000
1,500 lots 150,000 HK$ 3,495,000
2,000 lots 200,000 HK$ 4,660,000
Pool B
Lots SubscribedShares SubscribedSubscription Amount (HKD)
2,500 lots 250,000 HK$ 5,825,000
3,000 lots 300,000 HK$ 6,990,000
3,500 lots 350,000 HK$ 8,155,000
4,000 lots 400,000 HK$ 9,320,000
4,500 lots 450,000 HK$ 10,485,000
5,000 lots 500,000 HK$ 11,650,000
6,000 lots 600,000 HK$ 13,980,000
7,000 lots 700,000 HK$ 16,310,000
10,000 lots 1,000,000 HK$ 23,300,000
15,000 lots 1,500,000 HK$ 34,950,000
20,000 lots 2,000,000 HK$ 46,600,000
23,310 lots 2,331,000 HK$ 54,312,300

Stock Connect Inclusion Analysis

26Q4 Regular Review
Inclusion Pathway Regular Path
Avg Daily HK Mkt Cap HK$ 4.69B
Est. Threshold HK$ 9.73B
Analysis Result HK market cap below threshold, need +107%

Valuation & Financials

Market Cap (at Offer Price)To be extracted
Pre-IPO Valuation (Last Round)Not disclosed
P/E RatioNot disclosed
Profit/Loss StatusTo be extracted
Period-End Cash BalanceUSD 5.07 million
Listing Expenses~HK$ 199,680,000
Listing Expenses / Funds Raised~18.3%
Total Pre-IPO Investmentapproximately USD 167.2 million
First Day CloseHK$ 30.0
First Day OpenHK$ 29.0
First Day Change28.76%
First Day Volume9178740.0
First Day Turnover274943000.0
Use of Proceeds
1、約449.3百萬港元或51%預計將主要用于公司核心產品GASTROClearTM的研發、監管備案以及生產及商業化; 2、約211.0百萬港元或24%將為正在進行及計劃進行的研發提供資金,以進一步開發公司的管線產品; 3、約132.1百萬港元或15%將用于加強并整合公司的「端到端」能力,以把握價值鏈上的巨大商業潛力; 4、約88.0百萬港元或10%將用作公司的營運資金及其他一般公司用途。

Underwriting Syndicate

Joint Sponsors (2)
CHINA INTERNATIONAL CAPITAL CORPORATION HONG KONG SECURITIES LIMITED CE AEN894 建银国际金融有限公司 CE AJO225
Overall Coordinators (3)
CHINA INTERNATIONAL CAPITAL CORPORATION HONG KONG SECURITIES LIMITED CE AEN894 建银国际金融有限公司 CE AJO225 民银证券有限公司 CE APU820
Joint Bookrunners (8)
CHINA INTERNATIONAL CAPITAL CORPORATION HONG KONG SECURITIES LIMITED CE AEN894 建银国际金融有限公司 CE AJO225 民银证券有限公司 CE APU820 招银国际融资有限公司 CE AVM940 东吴证券国际经纪有限公司 CE AYA587 Livermore Holdings Limited CE BJN764 交银国际证券有限公司 CE APJ121 PLATINUM BROKING COMPANY LIMITED CE ADD980
Joint Lead Managers (13)
CHINA INTERNATIONAL CAPITAL CORPORATION HONG KONG SECURITIES LIMITED CE AEN894 建银国际金融有限公司 CE AJO225 民银证券有限公司 CE APU820 招银国际融资有限公司 CE AVM940 东吴证券国际经纪有限公司 CE AYA587 Livermore Holdings Limited CE BJN764 交银国际证券有限公司 CE APJ121 PLATINUM BROKING COMPANY LIMITED CE ADD980 Waton Securities International Limited CE AAK004 Alpha Win Capital Limited CE BNI045 IMPERIUM INTERNATIONAL SECURITIES LIMITED CE AVI905 KINGKEY SECURITIES GROUP LIMITED CE AXG710 Yuen Meta (International) Securities Limited CE BIL855

Cornerstone Investors

#Investor NameInvestment AmountShares Subscribed% of Offer Shares% of Total SharesLock-up PeriodEst. Unlock Date
1 Evergreen Gate Limited 61,446,760 HKD — 5.66% — 6 months 2025-11-23
2 北京浔瑞企业管理合伙企业(有限合伙) 387,926,360 HKD — 35.71% — 6 months 2025-11-23

Directors & Management

PositionChinese nameEnglish Name
Chairman朱興奮—
Company Secretary蕭月秋,歐陽葦芝—
No director data available.

Major Shareholders

Major Shareholders & HoldingsCentral Road Holdings Limited(18.31%),朱興奮(11.73%),SLW Gene Limited(6.75%),Accurate Gene Limited(6.46%),MSEA Ltd(5.49%)
AI AI Analysis AI interpretation deepseek-v4-pro · AI-generated
!
Underlying data failed quality checks; AI interpretation downgraded and shown for reference only.

Market Sentiment

The IPO's oversubscription ratio of 25.51x indicates moderate retail enthusiasm, with the offer price of HK$23.30 likely set at an attractive level. The 0.0% hit rate and triggered reallocation point to extreme scarcity in retail allotments, typical of hot IPOs where single-lot allocations dominate. Market sentiment appears cautiously optimistic, driven by the biotech sector's speculative appeal. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Tier Analysis

A clear tier anomaly is present: both 甲尾 (A-tail) at a HK$200,000 application and 乙头 (B-head) at HK$250,000 are expected to receive just 1 lot each, offering zero incremental benefit for the higher B-head commitment. This flat allocation structure makes the B-head tier exceptionally cost-inefficient relative to the A-tail, as the extra HK$50,000 yields no additional shares. Investors might rationally avoid the B-head unless seeking to avoid odd-lot complications, though broker fee differentials could slightly alter this calculus. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

Demographics

Demographic data is absent for this IPO, with mainland and Hong Kong participation both reported at 0%, likely due to data collection lag or omissions. Without reliable breakdowns, trends in mainland capital inflow, gender splits, or regional concentration cannot be assessed. This limitation prevents any meaningful demographic pattern analysis for this offering. (This is AI-generated commentary based on historical data. Past patterns do not guarantee future outcomes. Not financial advice.)

About this page

This page shows Mirxes-B (02629) prospectus details: offer price range, fundraise size, cornerstone investors, greenshoe, Pool A/B allocation and syndicate. For eligible IPOs it also provides a Stock Connect inclusion analysis, indicating the pathway and estimated timing for Southbound Connect admission; for A-share / US secondary listings, it additionally compares the other market's price, exchange rate and the H-share premium/discount. Data is parsed from the HKEX prospectus and related announcements. New to IPO subscription? See Hong Kong IPO Subscription 101.

Cibo — HK IPO Allotment Forecasts, Allottee Profiling & Stock Connect